Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 03, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Irisbiosciences a New Player in 3D Cell Culture
Friday, February 14, 2014
Irisbiosciences is focused on the development, manufacturing and marketing of products for bio-/pharmaceutical research and development, namely 3D cell culture products, tissue models and human & stem cells for in-vitro experimentation.

New Article by Spinnovation Biologics’ CEO Frederic Girard
Friday, February 07, 2014
New article details NMR for Quality by Design biologics development.

Phasefocus Announces the Availability of the VL Series of Live Cell Imaging Systems
Wednesday, February 05, 2014
A family of phase microscopy systems for live cell imaging.

Virtual Microscope Images at Fingertips
Tuesday, January 28, 2014
Olympus launches its OlyVIA Mobile iPad App, an image viewer dedicated to virtual slides.

Seward Stomacher® used for hygiene monitoring and biosecurity
Monday, January 27, 2014
Sponge swab and Stomacher technique proved to be highly effective sampling combination for assessing large surface areas

Hamamatsu Introduces New Addition to the ORCA-Flash4.0 Family
Wednesday, January 15, 2014
Bigger, faster images with the exceptional new ORCA-Flash4.0 LT Gen II scientific CMOS camera.

NanoSight's NTA Applied in the Veterinary Research Institute, Brno
Wednesday, January 08, 2014
The central theme of the research is to apply synthetic and bioorganic chemistry.

Asylum Research Announces the 4th Euro AFM Forum
Tuesday, January 07, 2014
The Euro AFM Forum at Georg-August Universität Göttingen to be held March 17-19, 2014.

Ready-to-Use Stable Cell Lines
Thursday, January 02, 2014
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 233
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv